site stats

Dyne therapeutics stock

Web19 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Dyne Therapeutics (DYN) WebApr 6, 2024 · 91,5%. More Financials. Company. Dyne Therapeutics Inc. is a muscle disease company. The Company is focused on advancing therapeutics for patients with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases.

Dyne hits four-month high as Guggenheim starts with Buy

WebApr 13, 2024 · Dyne Therapeutics Inc (DYN) stock is trading at $8.97 as of 3:43 PM on Thursday, Apr 13, a gain of $0.44, or 5.19% from the previous closing price of $8.53. The stock has traded between $8.49 and $9.15 so far today. Volume today is 467,568 compared to average volume of 400,449. WebGet the latest Dyne Therapeutics Inc (DYN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … diy splash guard for litter box https://epicadventuretravelandtours.com

DYNE THERAPEUTICS, INC. : DYN Stock Price - MarketScreener

WebDyne Therapeutics General Information. Description. Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. WebARF Manager. Genocea Biosciences. Sep 2024 - Feb 20243 years 6 months. Cambridge, MA. WebApr 10, 2024 · 5 brokerages have issued twelve-month target prices for Dyne Therapeutics' shares. Their DYN share price forecasts range from $18.00 to $34.00. On average, they … diy splatter screen pumpkin craft

Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Consensus …

Category:Should You Add Dyne Therapeutics Inc (DYN) Stock to Your …

Tags:Dyne therapeutics stock

Dyne therapeutics stock

Dyne Therapeutics NasdaqGS:DYN Stock Report - Simply Wall St

WebThe Dyne Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention. WebGet the latest Dyne Therapeutics, Inc. (DYN) stock news and headlines to help you in your trading and investing decisions. ... Raymond James has upgraded Dyne Therapeutics Inc (NASDAQ: DYN) from ...

Dyne therapeutics stock

Did you know?

WebHere's Why Dyne Therapeutics, Inc. (DYN) Is a Great 'Buy the Bottom' Stock Now Zacks - Fri Dec 9, 2024 . Dyne Therapeutics, Inc. (DYN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement... WebDyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a …

WebStock Price Forecast. The 8 analysts offering 12-month price forecasts for Dyne Therapeutics Inc have a median target of 28.00, with a high estimate of 47.00 and a low estimate of 20.00. The median estimate represents a +199.15% increase from the last price of … WebJan 26, 2024 · Dyne Therapeutics (DYN) reached the highest level since September as Guggenheim launched its coverage with a Buy rating citing its potential in muscular diseases. Read the full story here.

WebApr 11, 2024 · Let’s start up with the current stock price of Dyne Therapeutics Inc. (DYN), which is $8.82 to be very precise. The Stock rose vividly during the last session to $9.35 after opening rate of $9.34 while the lowest price it went was recorded $8.77 before closing at $9.38.Recently in News on March 23, 2024, Dyne Therapeutics Receives FDA …

WebDYN Stock 12 Months Forecast. Based on 4 Wall Street analysts offering 12 month price targets for Dyne Therapeutics in the last 3 months. The average price target is $28.50 with a high forecast of $34.00 and a low forecast of $20.00. The average price target represents a 155.61% change from the last price of $11.15.

WebFeb 27, 2024 · The 86 rating InvestorsObserver gives to Dyne Therapeutics Inc stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 99 percent of stocks in the Biotechnology industry, DYN’s 86 overall rating means the stock scores better than 86 percent of all stocks. cranley vs whaleyWebJan 26, 2024 · Dyne Therapeutics (DYN) reached the highest level since September as Guggenheim launched its coverage with a Buy rating citing its potential in muscular … diy split ac installationWebApr 6, 2024 · Dyne Therapeutics. stock was originally listed at a price of $23.90 in Sep 17, 2024. If you had invested in Dyne Therapeutics stock at $23.90, your return over the last 2 years would have been -61.88%, for an annualized return of -38.26% (not including any dividends or dividend reinvestments). cranloch riding centre